News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
TMX Newsfile
NEWS
IN THE PRESS
Press Releases
Hemostemix Up-lists to TradeGateExchange in Germany
January 28, 2025
·
7 min read
Press Releases
Sharp Therapeutics Corp. Completes Share Consolidation
January 27, 2025
·
3 min read
Press Releases
American Aires Announces Record Preliminary Q4/2024 Performance & Provides 2025 Guidance
January 27, 2025
·
16 min read
Press Releases
Awakn Life Sciences Provides Update on R&D Programs, Progressing Novel Therapeutics for Alcohol Use Disorder and PTSD
January 27, 2025
·
8 min read
Press Releases
Biophytis Announces Its Participation to the BIOMED FORUM Investor Conference
January 27, 2025
·
2 min read
Press Releases
PreveCeutical Announces Non-Brokered Private Placement
January 24, 2025
·
4 min read
Press Releases
Moss Genomics Provides Corporate Update and Announces Shift in Business Strategy
January 24, 2025
·
8 min read
Press Releases
Entheon Announces Agreement to Acquire Mentis AI
January 24, 2025
·
5 min read
Press Releases
Hemostemix Up-Lists to OTCQB While it Presents its Global Scale-Up Strategy at Two Investor Conferences in Puerto Rico
January 23, 2025
·
7 min read
Press Releases
Phio Pharmaceuticals Announces Closing of $1.83 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
January 21, 2025
·
7 min read
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us